September 10th 2025
Nerandomilast, with a PDUFA date of Q4 2025, leads the potential breakthrough therapies, with inhaled treprostinil and admilparant advancing quickly behind.
ATS 2020: Novel At-home Rapid Influenza Diagnostic Test Demonstrates Good Sensitivity, Specificity
August 11th 2020New research presented at the American Thoracic Society 2020 Virtual meeting showed the novel Theraflu Home FluTest demonstrated good sensitivity and specificity for influenza A and B viruses.